Commonwealth Bank of Australia’s Anika Therapeutics ANIK Stock Holding History

Commonwealth Bank of Australia’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-12,891	Closed	-$530K	–	797
2014 Q1	$530K	Hold	12,891	–	–	﹤0.01%	1024
2013 Q4	$492K	Buy	+12,891	New	+$398K	﹤0.01%	1015

Other funds holding ANIK

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIM

Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

Commonwealth Bank of Australia's ANIK Position: Q2 2014 in Review

Commonwealth Bank of Australia sold out of Anika Therapeutics (ANIK) in Q2 2014, closing a stake of 12,891 shares — an estimated $530K sold.

Commonwealth Bank of Australia first reported a position in ANIK in Q4 2013 and held it in 2 quarters. The position peaked at $530K in Q1 2014. 162 funds tracked by Wall St. Rank hold ANIK as of Q2 2014.

Commonwealth Bank of Australia reported no remaining Anika Therapeutics position as of Q2 2014 after selling out during the quarter.
Commonwealth Bank of Australia sold 12,891 Anika Therapeutics shares in Q2 2014, an estimated $530K.
Commonwealth Bank of Australia first reported a position in Anika Therapeutics in Q4 2013 and held it in 2 quarters.
Commonwealth Bank of Australia's Anika Therapeutics position peaked at $530K in Q1 2014.
162 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2014.

Based on Commonwealth Bank of Australia's 13F filing for Q2 2014, filed 11 Aug 2014.